- Poor sleep can lead to chronic pain—and women are in higher risk – Medical Xpress
New research from Aalborg University sheds light on a possible cause: sleep. A new study shows that disturbed sleep increases the body's sensitivity … - Vertex Pharmaceuticals stock falls as pain drug fails in phase 2 – Seeking Alpha
Vertex Pharmaceuticals (VRTX) falls premarket as VX-993 fails Phase 2 pain study endpoint. - Working through pain? You're not alone. – Harvard Gazette
A new study of functional abilities in the U.S. labor market reveals a workforce both vulnerable and resilient, with a large majority of workers … - Vertex VX-993 Misses Primary Endpoint in Mid-Stage Trial, Ending Investigation for Acute Pain
In contrast, study participants in a reference arm who received a hydrocodone /acetaminophen combination experienced superior analgesic efficacy. 1. - Vertex Non-Opioid Pain Drug Flunks Proof-of-Concept Test, Ending Plans for a Pivotal Study
… pain after bunionectomy surgery. The 367 study participants were assessed according to a scale used to measure pain intensity. Results showed …
